{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:16:46Z","timestamp":1791407806091,"version":"4.3.3"},"reference-count":238,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.584723","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T05:48:21Z","timestamp":1605073701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Gizem","family":"Duru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1501894","article-title":"Rapid eradication of a bulky melanoma mass with one dose of immunotherapy","volume":"372","author":"Chapman","year":"2015","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cytogfr.2017.06.011","article-title":"Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors","volume":"36","author":"Dammeijer","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1017\/CBO9781107415324.004","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier","volume":"180","author":"Pai","year":"2020","journal-title":"Cancer Treat Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nm1699","article-title":"Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy","volume":"14","author":"Buckanovich","year":"2008","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705673104","article-title":"Tumor immune escape by the loss of homeostatic chemokine expression","volume":"104","author":"Pivarcsi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101956","article-title":"Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells","volume":"208","author":"Molon","year":"2011","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.36967","article-title":"Topography of cancer-associated immune cells in human solid tumors","volume":"7","author":"Kather","year":"2018","journal-title":"Elife"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes","volume":"15","author":"Khan","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune\u2013vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Cancer Immunother Perspect"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.10.006.ANTIANGIOGENESIS","article-title":"Antiangiogenesis strategies revisited: from starving Ttumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced: MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1439.Macrophage","article-title":"Macrophage Expression of HIF-1\u03b1 Suppresses T cell Function and Promotes Tumor Progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Lett"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T reg cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324270","article-title":"Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis","volume":"33","author":"Rodig","year":"2003","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002961","article-title":"Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium","volume":"186","author":"Shetty","year":"2011","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-015-2017-5","article-title":"Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas","volume":"127","author":"Nakashima","year":"2016","journal-title":"J Neurooncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm064","article-title":"Role of tumor endothelium in CD4+CD25+ regulatory T cell infiltration of human pancreatic carcinoma","volume":"99","author":"Nummer","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080099","article-title":"Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma","volume":"205","author":"Quezada","year":"2008","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25863.Sunitinib","article-title":"Immunity in Concert With Specific Vaccination","volume":"129","author":"Bose","year":"2011","journal-title":"Int J Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0374","article-title":"A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism","volume":"13","author":"Manning","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0153","article-title":"Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer","volume":"70","author":"Shrimali","year":"2010","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor Angiogenesis: Therapeutic Implications","volume":"285","author":"Sherwood","year":"1971","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2009.05.003","article-title":"Seminars in Cancer Biology The angiogenic switch in carcinogenesis","volume":"19","author":"Baeriswyl","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2174\/1566524033479465","article-title":"Fundamental Concepts of the Angiogenic Process","volume":"3","author":"Folkman","year":"2003","journal-title":"Curr Mol Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines5020034","article-title":"The role of angiogenesis in cancer treatment","volume":"5","author":"Mousa","year":"2017","journal-title":"Biomedicines"},{"key":"B42","article-title":"Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis","volume":"57","author":"Relf","year":"1997","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1023\/a:1026516920119","article-title":"Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer","volume":"19","author":"Rak","year":"2000","journal-title":"Cancer Metastasis Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors:Wounds That Do Not Heal","volume":"315","author":"Dvorak","year":"1986","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.99911","article-title":"The evolving relationship of wound healing and tumor stroma Find the latest version\u00a0: The evolving relationship of wound healing and tumor stroma","volume":"3","author":"Foster","year":"2018","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10684","article-title":"Intraoperative intravital microscopy permits the study of human tumour vessels","volume":"7","author":"Fisher","year":"2016","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.5772\/66714","article-title":"Hypoxia, angiogenesis and atherogenesis","volume-title":"Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy","author":"Heikal","year":"2017"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1956","article-title":"VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression","volume":"101","author":"Ohm","year":"2003","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.121","article-title":"Tumor stroma: A complexity dictated by the hypoxic tumor microenvironment","volume":"33","author":"Casazza","year":"2014","journal-title":"Oncogene"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02610-0","article-title":"Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours","volume":"9","author":"Sidibe","year":"2018","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710754114","article-title":"Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer","volume":"114","author":"Jung","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39506.phages","article-title":"Hypoxia-inducible factor 2 \u03b1 regulates macrophage function in mouse models of acute and tumor inflammation","volume":"120","author":"Imtiyaz","year":"2010","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202366109","article-title":"Hypoxia-inducible factor-1 alpha \u2013 dependent induction of FoxP3 drives regulatory T-cell abundance and function during in fl ammatory hypoxia of the mucosa","volume":"109","author":"Clambey","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0543-y","article-title":"Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors","volume":"7","author":"Rytelewski","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4161\/cam.28244","article-title":"Rho-GTPase signaling in leukocyte extravasation: An endothelial point of view","volume":"8","author":"Heemskerk","year":"2014","journal-title":"Cell Adhes Migr"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10493","article-title":"F-actin-rich contractile endothelial pores prevent vascular leakage during leukocyte diapedesis through local RhoA signalling","volume":"7","author":"Heemskerk","year":"2016","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90279-8","article-title":"Leukocyte-Endothelial Cell Recognition: Three (or More) Steps to Specificity and Diversity Minireview","volume":"67","author":"Butcher","year":"1991","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21541248.2016.1197872","article-title":"Leukocyte transendothelial migration: A local affair","volume":"8","author":"Schimmel","year":"2017","journal-title":"Small GTPases"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwx105.Selectins","article-title":"Selectins in cancer immunity","volume":"28","author":"Borsig","year":"2018","journal-title":"Glycobiology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00600","article-title":"Regulation of T cell trafficking by enzymatic synthesis of O-glycans","volume":"8","author":"Hobbs","year":"2017","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/ni1233","article-title":"Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses","volume":"6","author":"Wang","year":"2005","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nri1918","article-title":"The role of heparan sulphate in inflammation","volume":"6","author":"Parish","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.148619","article-title":"Probing the biomechanical contribution of the endothelium to lymphocyte migration: diapedesis by the path of least resistance","volume":"127","author":"Martinelli","year":"2014","journal-title":"J Cell Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1087-5","article-title":"Nuclear positioning facilitates amoeboid migration along the path of least resistance","volume":"568","author":"Renkawitz","year":"2019","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.090202","article-title":"Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors","volume":"175","author":"Akino","year":"2009","journal-title":"Am J Pathol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1567","article-title":"Tumor-associated endothelial cells with cytogenetic abnormalities","volume":"64","author":"Hida","year":"2004","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.04.017","article-title":"Genes that Distinguish Physiological and Pathological Angiogenesis","volume":"13","author":"Seaman","year":"2007","journal-title":"Cancer Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3700","article-title":"Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","article-title":"An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates","volume":"37","author":"Goveia","year":"2020","journal-title":"Cancer Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0181-9","article-title":"Vessel co-option in cancer","volume":"16","author":"Kuczynski","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a006536","article-title":"Tumor endothelial cells","volume":"2","author":"Dudley","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2011\/409308","article-title":"Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains Unchanged","volume":"2011","author":"Langenkamp","year":"2011","journal-title":"ISRN Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v88.2.667.bloodjournal882667","article-title":"Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium","volume":"88","author":"Griffioen","year":"1996","journal-title":"Blood"},{"key":"B77","article-title":"Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors","volume":"56","author":"Griffioen","year":"1996","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061890","article-title":"In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor","volume":"204","author":"Boissonnas","year":"2007","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.11.11.1473.Targeting","article-title":"Targeting selectins and selectin ligands in inflammation and cancer","volume":"11","author":"Barthel","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/0008-5472.CAN-08-2281.Chemokine","article-title":"Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21135","article-title":"Selective infiltration of CCR5 1 CXCR3 1 T lymphocytes in human colorectal carcinoma","volume":"956","author":"Musha","year":"2005","journal-title":"Int J Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3314","article-title":"Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the ontario familial breast cancer registry","volume":"19","author":"Mulligan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I","article-title":"Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma","volume":"189","author":"Kunz","year":"1999","journal-title":"J Pathol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2059","article-title":"CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease","volume":"64","author":"Mullins","year":"2004","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/onci.25752","article-title":"Interferon \u03b3-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes","volume":"2","author":"Guirnalda","year":"2013","journal-title":"Oncoimmunology"},{"key":"B86","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.161.2.927","article-title":"The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor","volume":"161","author":"Tannenbaum","year":"1998","journal-title":"J Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0351","article-title":"Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor","volume":"17","author":"Moon","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B88","article-title":"Tumor Necrosis Factor \u03b1-induced Leukocyte Adhesion in Normal and Tumor Vessels: Effect of Tumor Type, Transplantation Site, and Host Strain","volume":"55","author":"Fukumura","year":"1995","journal-title":"Cancer Res"},{"key":"B89","article-title":"Hypoxic Tumor Cell Death and Modulation of Endothelial Adhesion Molecules in the Regression of Granulocyte Colony-Stimulating","volume":"148","author":"Colombo","year":"1996","journal-title":"Am J Pathol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200385","article-title":"IL-17 and TNF-\u03b1 Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial Activation","volume":"188","author":"Griffin","year":"2012","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.158.CXCR3","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"B92","article-title":"Enhanced Induction of Very Late Antigen 4 \/ Lymphocyte Function-associated Antigen 1-dependent T-Cell Migration to Tumor Sites following Administration of Interleukin 12","volume":"57","author":"Ogawa","year":"1997","journal-title":"Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44952","article-title":"IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells","volume":"121","author":"Fisher","year":"2011","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.5861","article-title":"CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction","volume":"172","author":"Garbi","year":"2004","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2557","article-title":"Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-\u03b2","volume":"17","author":"Lohr","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1415","article-title":"LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor","volume":"183","author":"Schmits","year":"1996","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26223","article-title":"\u03b1 l\u03b2 2 integrin is indispensable for CD8 + T-cell recruitment in experimental pancreatic and hepatocellular cancer","volume":"130","author":"Takeichi","year":"2012","journal-title":"Int J Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.6.3416","article-title":"ICAM-1 Contributes to but Is Not Essential for Tumor Antigen Cross-Priming and CD8 + T Cell-Mediated Tumor Rejection In Vivo","volume":"174","author":"Blank","year":"2005","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4470","article-title":"Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse","volume":"6","author":"Yu K","year":"2015","journal-title":"Oncotarget"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1472-0","article-title":"Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas","volume":"62","author":"Langenes","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.13.3554","article-title":"Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties","volume":"98","author":"Proost","year":"2001","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s10014-014-0206-0","article-title":"The perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor","volume":"32","author":"Sugita","year":"2015","journal-title":"Brain Tumor Pathol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.784","article-title":"Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma","volume":"110","author":"Tanaka","year":"2014","journal-title":"Br J Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1017\/S1431927608080215","article-title":"T lymphocyte migration to lymph nodes is maintained during homeostatic proliferation","volume":"14","author":"Kodera","year":"2008","journal-title":"Microsc Microanal"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.099","article-title":"Effector and Regulatory T Cells Roll at High Shear Stress by Inducible Tether and Sling Formation","volume":"21","author":"Abadier","year":"2017","journal-title":"Cell Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2869","article-title":"Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers","volume":"13","author":"Yan","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1236","article-title":"Clever-1\/stabilin-1 controls cancer growth and metastasis","volume":"20","author":"Karikoski","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.002","article-title":"Natural killer cell-mediated immunosurveillance of human cancer","volume":"31","author":"Malmberg","year":"2017","journal-title":"Semin Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.smim.2017.08.003","article-title":"Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more","volume":"31","author":"Chiossone","year":"2017","journal-title":"Semin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/imr.12524","article-title":"New checkpoints in cancer immunotherapy","volume":"276","author":"Ni","year":"2017","journal-title":"Immunol Rev"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11825","article-title":"Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2017.613","article-title":"Tumor-associated macrophages derived TGF-\u03b2-induced epithelial to mesenchymal transition in colorectal cancer cells through Smad2,3-4\/Snail signaling pathway","volume":"51","author":"Cai","year":"2019","journal-title":"Cancer Res Treat"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3923","article-title":"TGF-\u03b21 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2\/3 signalling pathway","volume":"42","author":"Liu","year":"2018","journal-title":"Int J Mol Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The Broad Spectrum of Human Natural Killer Cell Diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3126","article-title":"Natural killer cells require selectins for suppression of subcutaneous tumors","volume":"69","author":"Sobolev","year":"2009","journal-title":"Cancer Res"},{"key":"B117","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.156.12.4707","article-title":"NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1\/VLA-4 interaction","volume":"156","author":"Fogler","year":"1996","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02324","article-title":"Molecular mechanisms directing migration and retention of natural killer cells in human tissues","volume":"9","author":"Castriconi","year":"2018","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: Neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0784","article-title":"Monocyte induction of E-selectin-mediated endothelial activation releases VE-cadherin junctions to promote tumor cell extravasation in the metastasis cascade","volume":"76","author":"H\u00e4uselmann","year":"2016","journal-title":"Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3121","article-title":"L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest","volume":"66","author":"L\u00e4ubli","year":"2006","journal-title":"Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63580-8","article-title":"Infiltration of Neutrophils Is Required for Acquisition of Metastatic Phenotype of Benign Murine Fibrosarcoma Cells: Implication of Inflammation-Associated Carcinogenesis and Tumor Progression","volume":"163","author":"Tazawa","year":"2003","journal-title":"Am J Pathol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911378107","article-title":"Inhibition of Mac-1 (CD11b\/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-013-1354-5","article-title":"IL-17A potentiates TNF\u03b1-induced secretion from human endothelial cells and alters barrier functions controlling neutrophils rights of passage","volume":"466","author":"Bosteen","year":"2014","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0188","article-title":"CXCR2-dependent accumulation of tumor-associated neutrophils regulates T-cell immunity in pancreatic ductal adenocarcinoma","volume":"4","author":"Chao","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/2162402X.2017.1373234","article-title":"IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma","volume":"7","author":"Chen","year":"2017","journal-title":"Oncoimmunology"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.11.005.Neutrophils","article-title":"Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells","volume":"28","author":"Blaisdell","year":"2015","journal-title":"Cancer Cell"},{"key":"B131","article-title":"Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12","volume":"59","author":"Cavallo","year":"1999","journal-title":"Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0090","article-title":"Antiangiogenesis targeting tumor microenvironment synergizes glucuronide prodrug antitumor activity","volume":"15","author":"Juan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09762","article-title":"Tumor-Endothelium Cross Talk Blocks Recruitment of Neutrophils to Endothelial Cells: A Novel Mechanism of Endothelial Cell Anergy","volume":"11","author":"Blaheta","year":"2009","journal-title":"Neoplasia"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/120328","article-title":"ICAM-1 clustering on endothelial cells recruits VCAM-1","volume":"2010","author":"van Buul","year":"2010","journal-title":"J BioMed Biotechnol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01817","article-title":"Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment","volume":"10","author":"Jeong","year":"2019","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.014","article-title":"Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression","volume":"41","author":"Chittezhath","year":"2014","journal-title":"Immunity"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26790","article-title":"Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha\/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1032","article-title":"IFN\u03b3 and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma","volume":"6","author":"Long","year":"2016","journal-title":"Cancer Discovery"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04355-w","article-title":"Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking","volume":"9","author":"Porrello","year":"2018","journal-title":"Nat Commun"},{"key":"B142","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","article-title":"Angiotensin II Drives the Production of Tumor-Promoting Macrophages","volume":"38","author":"Cortez-Retamozo","year":"2013","journal-title":"Immunity"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/2162402X.2018.1470729","article-title":"Recruitment of CCR2 + tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer","volume":"7","author":"Grossman","year":"2018","journal-title":"Oncoimmunology"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1910856117","article-title":"CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas","volume":"117","author":"Flores-Toro","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.261704098","article-title":"Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis","volume":"99","author":"Borsig","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2704","article-title":"Integrin \u03b14\u03b21 promotes monocyte trafficking and angiogenesis in tumors","volume":"66","author":"Jin","year":"2006","journal-title":"Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-10979-3","article-title":"Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma","volume":"10","author":"Czystowska-Kuzmicz","year":"2019","journal-title":"Nat Commun"},{"key":"B148","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2006.12.012","article-title":"CCL2\/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers","volume":"252","author":"Huang","year":"2007","journal-title":"Cancer Lett"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9407","article-title":"Patrolling monocytes control tumor metastasis to the lung","volume":"350","author":"Hanna","year":"2015","journal-title":"Science (80- )"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01433-3","article-title":"Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche","volume":"8","author":"Plebanek","year":"2017","journal-title":"Nat Commun"},{"key":"B152","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0082","article-title":"Primary tumors limit metastasis formation through induction of IL15-mediated cross-talk between patrolling monocytes and NK cells","volume":"5","author":"Kubo","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93182","article-title":"Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy","volume":"127","author":"Jung","year":"2017","journal-title":"J Clin Invest"},{"key":"B155","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Science (80- )"},{"key":"B156","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1242\/jcs.072728","article-title":"Intravital microscopy: new insights into metastasis of tumors","volume":"124","author":"Beerling","year":"2011","journal-title":"J Cell Sci"},{"key":"B157","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ctrv.2010.05.001","article-title":"The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents","volume":"37","author":"Siemann","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1608384113","article-title":"Pericyte-fibroblast transition promotes tumor growth and metastasis","volume":"113","author":"Hosaka","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are tumour blood vessels abnormal and why is it important to know","volume":"100","author":"Nagy","year":"2009","journal-title":"Br J Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.01.003","article-title":"Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy","volume":"65","author":"Abou Khouzam","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B161","article-title":"Hypoxia promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells via inducing Twist1 expression","volume":"21","author":"Zhang","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3087","article-title":"Hypoxia-inducible factor 1\u03b1 promotes primary tumor growth and tumor-initiating cell activity in breast cancer","volume":"14","author":"Schwab","year":"2012","journal-title":"Breast Cancer Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(03)00166-8","article-title":"Oxygen-regulated expression of TGF-\u03b23, a growth factor involved in trophoblast differentiation","volume":"24","author":"Sch\u00e4ffer","year":"2003","journal-title":"Placenta"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1639","article-title":"Hypoxia-inducible factor-1 transactivates transforming growth factor-\u03b23 in trophoblast","volume":"145","author":"Nishi","year":"2004","journal-title":"Endocrinology"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605486","article-title":"Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion","volume":"102","author":"Chen","year":"2010","journal-title":"Br J Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis","volume":"20","author":"Mandriota","year":"2001","journal-title":"EMBO J"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071420","article-title":"Lymphatic metastasis in the absence of functional intratumor lymphatics","volume":"296","author":"Padera","year":"2002","journal-title":"Science (80- )"},{"key":"B170","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/dji003","article-title":"Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody","volume":"97","author":"Pytowski","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.001","article-title":"Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization","volume":"18","author":"Tvorogov","year":"2010","journal-title":"Cancer Cell"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2010.10.008","article-title":"Vessel abnormalization: Another hallmark of cancer? Molecular mechanisms and therapeutic implications","volume":"21","author":"De Bock","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat Rev Drug Discovery"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1693-x","article-title":"Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma","volume":"122","author":"Levin","year":"2015","journal-title":"J Neurooncol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"key":"B176","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0403","article-title":"Lessons from phase III clinical trials on anti-VEGF therapy for cancer","volume":"3","author":"Jain","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-3073","article-title":"Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas","volume":"16","author":"Chae","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40265-7","article-title":"Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci Transl Med"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/nature07424","article-title":"A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation","volume":"456","author":"Greenberg","year":"2008","journal-title":"Nature"},{"key":"B181","article-title":"Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy","volume":"60","author":"Hansen-Algenstaedt","year":"2000","journal-title":"Cancer Res"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2441","article-title":"Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization","volume":"13","author":"Dings","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.12.010.Improved","article-title":"Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation","volume":"76","author":"Mcgee","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.10.011","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors","volume":"64","author":"Tong","year":"2004","journal-title":"Cancer Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","article-title":"Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts","volume":"165","author":"Inai","year":"2004","journal-title":"Am J Pathol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1558","article-title":"Vascular Endothelial Growth Factor Blockade Reduces Intratumoral Regulatory T Cells and Enhances the Efficacy of a GM-CSF ^ Secreting Cancer Immunotherapy","volume":"12","author":"Li","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-014-0294-y","article-title":"Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine","volume":"12","author":"Kwilas","year":"2014","journal-title":"J Transl Med"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci Transl Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1852","article-title":"Active immunotherapy induces antibody responses that target tumor angiogenesis","volume":"70","author":"Schoenfeld","year":"2010","journal-title":"Cancer Res"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0407-1","article-title":"Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model","volume":"13","author":"Renner","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0777-3","article-title":"Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models","volume":"31","author":"Tao","year":"2014","journal-title":"Med Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2013.19","article-title":"Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency","volume":"20","author":"Wang","year":"2013","journal-title":"Gene Ther"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12069","article-title":"Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2 ) induces synergistic anti-tumour effect in vivo","volume":"172","author":"Yasuda","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"6988","DOI":"10.1158\/0008-5472.CAN-16-0888","article-title":"Efficacy of cotargeting angiopoietin-2 and the VEGF pathway in the adjuvant postsurgical setting for early breast, colorectal, and renal cancers","volume":"76","author":"Wu","year":"2016","journal-title":"Cancer Res"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24652","article-title":"Regression of Established Hepatocellular Carcinoma Is Induced by Chemoimmunotherapy in an Orthotopic Murine Model","volume":"55","author":"Avella","year":"2012","journal-title":"Hepatology"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26219","article-title":"Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy","volume":"130","author":"Farsaci","year":"2012","journal-title":"In J Cancer"},{"key":"B199","article-title":"Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs","volume":"6","author":"Du Four","year":"2016","journal-title":"Am J Cancer Res"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2176","article-title":"Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer","volume":"78","author":"Meder","year":"2018","journal-title":"Cancer Res"},{"key":"B201","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1158\/2326-6066.CIR-16-0206.Angiopoietin-2","article-title":"Angiopoietin-2 as a biomarker and target for immune checkpoint therapy","volume":"5","author":"Wu","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30889","article-title":"Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma","volume":"71","author":"Shigeta","year":"2020","journal-title":"Hepatology"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065757","article-title":"Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models","volume":"8","author":"Shi","year":"2013","journal-title":"PloS One"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0278","article-title":"Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy","volume":"13","author":"Dickson","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.07.001","article-title":"Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage","volume":"18","author":"Koh","year":"2010","journal-title":"Cancer Cell"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525349113","article-title":"Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages","volume":"113","author":"Peterson","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.5561","article-title":"Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: Final results of CALGB 90206","volume":"28","author":"Rini","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7849","article-title":"Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): Final analysis of overall survival","volume":"28","author":"Escudier","year":"2010","journal-title":"J Clin Oncol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-015-0055-3","article-title":"Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results","volume":"3","author":"Amin","year":"2015","journal-title":"J Immunother Cancer"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.371","article-title":"Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma","volume":"2","author":"Hodi","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-018-0420-0","article-title":"Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: The CheckMate 016 study","volume":"6","author":"Amin","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1634\/theoncologist.2018-0044","article-title":"Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)","volume":"23","author":"Arkenau","year":"2018","journal-title":"Oncologist"},{"key":"B213","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.19.01882","article-title":"Results of a multicenter phase II study of atezolizumab and bevacizumab for patients with metastatic renal cell carcinoma with variant histology and\/or sarcomatoid features","volume":"38","author":"McGregor","year":"2020","journal-title":"J Clin Oncol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.06.033","article-title":"Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non\u2013small-cell lung cancer","volume":"101","author":"Liu","year":"2018","journal-title":"Eur J Cancer"},{"key":"B215","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S2213-2600(19)30084-0","article-title":"Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial","volume":"7","author":"Reck","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N Engl J Med"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30107-4","article-title":"Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial","volume":"19","author":"Choueiri","year":"2018","journal-title":"Lancet Oncol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.010","article-title":"Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma","volume":"31","author":"Choueiri","year":"2020","journal-title":"Ann Oncol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma","volume":"176","author":"Motzer","year":"2018","journal-title":"Physiol Behav"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2484","article-title":"Anti-PD-1 antibody SHR-1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer: An Open-label, Dose Escalation and Expansion Study","volume":"25","author":"Xu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B221","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment","volume":"245","author":"Huo","year":"2017","journal-title":"J Control Release"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N Engl J Med"},{"key":"B223","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4161\/onci.22664","article-title":"Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated t cells in recurrent ovarian cancer","volume":"2","author":"Kandalaft","year":"2013","journal-title":"Oncoimmunology"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"B225","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cmet.2013.11.008","article-title":"Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis","volume":"19","author":"Schoors","year":"2014","journal-title":"Cell Metab"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"B227","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10456-017-9573-6","article-title":"Tumor vessel disintegration by maximum tolerable PFKFB3 blockade","volume":"20","author":"Conradi","year":"2017","journal-title":"Angiogenesis"},{"key":"B228","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","article-title":"Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis","volume":"31","author":"Rohlenova","year":"2020","journal-title":"Cell Metab"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118296109","article-title":"Tumor-targeted TNF\u03b1 stabilizes tumor vessels and enhances active immunotherapy","volume":"109","author":"Johansson","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101877","article-title":"Targeting TNF-\u03b1 to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy","volume":"188","author":"Calcinotto","year":"2012","journal-title":"J Immunol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1436","article-title":"The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases","volume":"67","author":"Rybak","year":"2007","journal-title":"Cancer Res"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1197-1271","article-title":"Targeting by affinity\u2013matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform","volume":"15","author":"Neri","year":"1997","journal-title":"Nat Biotechnol"},{"key":"B233","article-title":"Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer","volume":"9","author":"Santimaria","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.07.033","article-title":"The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase i clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma","volume":"46","author":"Johannsen","year":"2010","journal-title":"Eur J Cancer"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1659","article-title":"Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix","volume":"99","author":"Carnemolla","year":"2002","journal-title":"Blood"},{"key":"B236","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00262-015-1704-6","article-title":"Intralesional administration of L19 \u2212 IL2 \/ L19 \u2212 TNF in stage III or stage IVM1a melanoma patients\u00a0: results of a phase II study","volume":"65","author":"Danielli","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1733","article-title":"Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes","volume":"71","author":"Palaz\u00f3n","year":"2011","journal-title":"Cancer Res"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4071","article-title":"A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo","volume":"36","author":"Li","year":"2018","journal-title":"Nat Biotechnol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.584723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:05:30Z","timestamp":1697072730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.584723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":238,"alternative-id":["10.3389\/fimmu.2020.584723"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.584723","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"article-number":"584723"}}